Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Xortx Therapeutics Inc (XRTXF)

Xortx Therapeutics Inc (XRTXF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade XRTXF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2853 +53.77%
on 08/27/21
0.6972 -37.08%
on 09/08/21
+0.1281 (+41.24%)
since 08/20/21
3-Month
0.1197 +266.50%
on 06/30/21
0.6972 -37.08%
on 09/08/21
+0.3169 (+260.18%)
since 06/21/21
52-Week
0.0715 +513.57%
on 11/19/20
0.6972 -37.08%
on 09/08/21
+0.3095 (+239.55%)
since 09/10/20

Most Recent Stories

More News
XORTX Therapeutics Announces Closing of US$12 Million Public Offering

CALGARY, Alberta, Oct. 15, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical...

XRX.CN : 4.800 (unch)
XRTX : 1.3500 (+3.85%)
XRTXF : 0.4387 (-1.50%)
XORTX Announces Results from Mount Sinai’s COVID-19 Clinical Study

Early, High Uric Acid is Independently Associated with Acute Kidney Injury and Mortality in COVID-19...

XRX.CN : 4.800 (unch)
XRTX : 1.3500 (+3.85%)
XRTXF : 0.4387 (-1.50%)
XORTX to Present at the LD Micro Main Event

Virtual Corporate Presentation – October 14, 2021 – 10 am ET...

XRX.CN : 4.800 (unch)
XRTX : 1.3500 (+3.85%)
XRTXF : 0.4387 (-1.50%)
XORTX Therapeutics Announces Pricing of US$12 Million Public Offering and Nasdaq Listing

CALGARY, Alberta, Oct. 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical...

XRX.CN : 4.800 (unch)
XRTXF : 0.4387 (-1.50%)
Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

OTCM : 56.8000 (+1.81%)
SEOVF : 1.2000 (+0.31%)
SHGFF : 5.6450 (+1.71%)
BABYF : 1.0800 (+1.89%)
XRTXF : 0.4387 (-1.50%)
CRTPF : 2.3000 (+5.50%)
VVIVF : 0.2210 (-5.56%)
AVCNF : 0.3145 (+11.60%)
ORXOY : 1.8800 (+2.73%)
SVA.VN : 1.520 (unch)
SHG.VN : 6.800 (+5.92%)
BABY.VN : 1.170 (unch)
XORTX to Present at "Zoom With LD MICRO"

CALGARY, AB / ACCESSWIRE / March 16, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive...

XRX.CN : 4.800 (unch)
XRTXF : 0.4387 (-1.50%)
XORTX to Present and Participate in the Sachs 14th Annual European Life Sciences CEO Forum 2021

CALGARY, AB / ACCESSWIRE / March 9, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX)(OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive...

XRTXF : 0.4387 (-1.50%)
XRX.CN : 4.800 (unch)
XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection

Compositions and Methods for Enhancing Anti-viral Therapies CALGARY, AB / ACCESSWIRE / March 8, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company...

XRTXF : 0.4387 (-1.50%)
XRX.CN : 4.800 (unch)
XORTX to Present at BIO CEO and Investor Conference; Strategies to Decrease Acute and Chronic Kidney Injury, Co-morbidity and Mortality

CALGARY, AB / ACCESSWIRE / February 17, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX)(OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat...

XRX.CN : 4.800 (unch)
XRTXF : 0.4387 (-1.50%)
XORTX Announces Over Subscribed Private Placement

CALGARY, AB / ACCESSWIRE / February 8, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX)(OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat...

XRX.CN : 4.800 (unch)
XRTXF : 0.4387 (-1.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.5223
2nd Resistance Point 0.4941
1st Resistance Point 0.4664
Last Price 0.4387
1st Support Level 0.4105
2nd Support Level 0.3823
3rd Support Level 0.3546

See More

52-Week High 0.6972
Fibonacci 61.8% 0.4582
Last Price 0.4387
Fibonacci 50% 0.3844
Fibonacci 38.2% 0.3105
52-Week Low 0.0715

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar